Presentation is loading. Please wait.

Presentation is loading. Please wait.

273 Bivalirudin Versus Heparin-Monotherapy in All Comers After Percutaneous Intervention: The Québec Heart-Lung Institute Experience  J. MacHaalany, E.

Similar presentations


Presentation on theme: "273 Bivalirudin Versus Heparin-Monotherapy in All Comers After Percutaneous Intervention: The Québec Heart-Lung Institute Experience  J. MacHaalany, E."— Presentation transcript:

1 273 Bivalirudin Versus Heparin-Monotherapy in All Comers After Percutaneous Intervention: The Québec Heart-Lung Institute Experience  J. MacHaalany, E. Abdelaal, Y. Bataille, É. Larose, J. Déry, R. Delarochellière, S. Rinfret, L. Roy, G. Proulx, O. Gleeton, J. Rodés- Cabau, B. Noël, G. Barbeau, C. Nguyen, O. Costerousse, O.F. Bertrand  Canadian Journal of Cardiology  Volume 28, Issue 5, (September 2012) DOI: /j.cjca Copyright © 2012 Canadian Cardiovascular Society Terms and Conditions

2 Canadian Journal of Cardiology 2012 28, DOI: (10. 1016/j. cjca. 2012
Copyright © 2012 Canadian Cardiovascular Society Terms and Conditions


Download ppt "273 Bivalirudin Versus Heparin-Monotherapy in All Comers After Percutaneous Intervention: The Québec Heart-Lung Institute Experience  J. MacHaalany, E."

Similar presentations


Ads by Google